Skip to main content
Premium Trial:

Request an Annual Quote

Novacyt: James McCarthy, Anthony Dyer

Clinical diagnostics firm Novacyt has appointed James McCarthy as its CFO and Anthony Dyer to a new role as its chief corporate development officer. McCarthy will become a board director, subject to shareholder approval at the company's annual general meeting. Dyer will remain a board director until then.

McCarthy has held senior positions in listed and private equity-backed businesses. He was CFO of Flint Group, and of Brambles' Europe, Middle East, and Africa-based Commonwealth Handling Equipment Pool (CHEP) business before being promoted to president of CHEP’s European team.

McCarthy trained as an accountant with Dairygold and has worked for Unilever and ICI, among other companies.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.